The prevalence of severe anaphylaxis, between 1 and 3 per 10?000, has increased sharply over recent years, with a rate of lethality of 1%. The economic burden is unknown. Objective:? The aim of this study was to estimate the economic costs of anaphylaxis, including direct costs of ...
hydroxylamine and then oxidized to sulfamethoxazole-nitroso, which stimulates both T and B cells. Other examples are phenacetin, halothane, phenytoin, carbamazepine, and lamotrigine.[10][11] There is a concept of a direct immune response to medications and drugs or even biologic therapies that use ...
It can develop into chronic inflammatory conditions upon continuous allergen exposure, and the exact mechanism remains unknown [3, 4]. The diagnoses of AR and ACD mainly depend on the occurrence history, regular clinical laboratory tests, skin prick tests and epicutaneous patch tests [2, 5]. ...
Chronic spontaneous urticaria (CSU), formerly known as chronic idiopathic urticaria (CIU) is defined by the spontaneous development of itchy hives and/or angioedema that reoccur for at least 6 weeks due to known or unknown causes [1]. CSU/CIU is thought to affect 0.5–1 % of the global ...
Unknown changes in drug risks for SJS/TEN can be a major problem in public health. Therefore, an extensive ascertainment of cases is necessary. The stable overall incidence indicates that the coverage of the German Registry is very high and no larger proportion of cases is missed. These data ...